N. Krone, Congenital adrenal hyperplasia and P450 oxidoreductase deficiency, Clinical Endocrinology, vol.22, issue.2, pp.162-72, 2007.
DOI : 10.1210/jc.2005-2460

URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2265.2006.02740.x/pdf

P. C. White and P. W. Speiser, Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency, Endocrine Reviews, vol.21, issue.3, pp.245-91, 2000.
DOI : 10.1210/er.21.3.245

M. G. Forest, Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Human Reproduction Update, vol.10, issue.6, pp.469-85, 2004.
DOI : 10.1093/humupd/dmh047

J. P. Chanson, Traité d'endocrinologie, 2007.

N. Krone, Predicting Phenotype in Steroid 21-Hydroxylase Deficiency? Comprehensive Genotyping in 155 Unrelated, Well Defined Patients from Southern Germany, The Journal of Clinical Endocrinology & Metabolism, vol.85, issue.3, pp.1059-65, 2000.
DOI : 10.1210/jcem.85.3.6441

P. W. Speiser, Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency., Journal of Clinical Investigation, vol.90, issue.2, pp.90-584, 1992.
DOI : 10.1172/JCI115897

M. T. Tusie-luna, P. Traktman, and P. C. White, Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus, J Biol Chem, issue.34, pp.265-20916, 1990.

H. Blanche, Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women, Human Genetics, vol.101, issue.1, pp.56-60, 1997.
DOI : 10.1007/s004390050586

C. Deneux, Phenotype-Genotype Correlation in 56 Women with Nonclassical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.1, pp.207-220, 2001.
DOI : 10.1210/jcem.86.1.7131

B. L. Therrell and . Jr, Results of Screening 1.9 Million Texas Newborns for 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia, Pediatrics, vol.101, issue.4, pp.583-90, 1998.
DOI : 10.1542/peds.101.4.583

S. D. Grosse, G. Van, and . Vliet, How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia? Horm Res, pp.284-91, 2007.

L. Wilkins, The suppression of androgen secretion by cortisone in a case of congenital adrenal hyperplasia, Bull Johns Hopkins Hosp, vol.86, issue.4, pp.249-52, 1950.

S. F. Witchel and R. Azziz, Congenital Adrenal Hyperplasia, Journal of Pediatric and Adolescent Gynecology, vol.24, issue.3, pp.116-142
DOI : 10.1016/j.jpag.2010.10.001

U. Ambroziak, Congenital adrenal hyperplasia due to 21-hydroxylase deficiency management in adults, Endokrynol Pol, vol.61, issue.1, pp.142-55

R. J. Auchus and R. J. Auchus, Congenital adrenal hyperplasia in adults Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline, Management of the adult with congenital adrenal hyperplasia, pp.614107-614123, 2002.

K. Muthusamy, Adult Height in Patients with Congenital Adrenal Hyperplasia: A Systematic Review and Metaanalysis, The Journal of Clinical Endocrinology & Metabolism, vol.95, issue.9, pp.4161-72
DOI : 10.1210/jc.2009-2616

J. Jaaskelainen and R. Voutilainen, Growth of Patients with 21-Hydroxylase Deficiency: An Analysis of the Factors Influencing Adult Height, Pediatric Research, vol.45, issue.1, pp.30-33, 1997.
DOI : 10.1136/adc.45.239.13

A. Grigorescu-sido, Growth Analysis in Patients with 21-Hydroxylase Deficiency Influence of Glucocorticoid Dosage, Age at Diagnosis, Phenotype and Genotype on Growth and Height Outcome, Hormone Research in Paediatrics, vol.60, issue.2, pp.84-90, 2003.
DOI : 10.1159/000071876

R. T. Kirkland, The Effect of Therapy on Mature Height in Congenital Adrenal Hyperplasia*, The Journal of Clinical Endocrinology & Metabolism, vol.47, issue.6, pp.47-1320, 1978.
DOI : 10.1210/jcem-47-6-1320

I. Manoli, Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome, Clinical Endocrinology, vol.84, issue.Suppl., pp.669-76, 2002.
DOI : 10.1111/j.1651-2227.1995.tb13789.x

W. M. Bukowski and D. Sandberg, Peer relationships and quality of life, Acta Paediatrica, vol.35, issue.s428, pp.108-117, 1999.
DOI : 10.2307/1129818

D. Knorr and S. G. , Hinrichsen de Lienau, Persistent obesity and short final height after corticoid overtreatment for congenital adrenal hyperplasia (CAH) in infancy, Acta Paediatr Jpn, p.30, 1988.

R. E. Cornean, P. C. Hindmarsh, and C. G. Brook, Obesity in 21-hydroxylase deficient patients, Archives of Disease in Childhood, vol.78, issue.3, pp.78-261, 1998.
DOI : 10.1136/adc.78.3.261

T. M. Volkl, Obesity Among Children and Adolescents With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency, PEDIATRICS, vol.117, issue.1, pp.98-105, 2006.
DOI : 10.1542/peds.2005-1005

URL : http://pediatrics.aappublications.org/content/pediatrics/117/1/e98.full.pdf

E. Charmandari, Children with Classic Congenital Adrenal Hyperplasia Have Elevated Serum Leptin Concentrations and Insulin Resistance: Potential Clinical Implications, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.5, pp.2114-2134, 2002.
DOI : 10.1210/jcem.87.5.8456

URL : https://academic.oup.com/jcem/article-pdf/87/5/2114/9156872/jcem2114.pdf

N. M. Stikkelbroeck, Normal Bone Mineral Density and Lean Body Mass, but Increased Fat Mass, in Young Adult Patients with Congenital Adrenal Hyperplasia, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.3, pp.1036-1078, 2003.
DOI : 10.1210/jc.2002-021074

C. Paganini, Height, Bone Mineral Density and Bone Markers in Congenital Adrenal Hyperplasia, Hormone Research in Paediatrics, vol.54, issue.4, pp.164-172, 2000.
DOI : 10.1159/000053253

K. Hagenfeldt, Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Eur J Endocrinol J Clin Endocrinol Metab, vol.143, issue.51, pp.667-71, 2000.

J. Helleday, Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab J Clin Endocrinol Metab Horm Res, vol.76, issue.366, pp.933-939, 1993.

W. Arlt, Health Status of Adults with Congenital Adrenal Hyperplasia: A Cohort Study of 203 Patients, The Journal of Clinical Endocrinology & Metabolism, vol.95, issue.11, pp.5110-5131
DOI : 10.1210/jc.2010-0917

E. Charmandari and G. P. Chrousos, Metabolic Syndrome Manifestations in Classic Congenital Adrenal Hyperplasia: Do They Predispose to Atherosclerotic Cardiovascular Disease and Secondary Polycystic Ovary Syndrome?, Annals of the New York Academy of Sciences, vol.87, issue.3, pp.37-53, 1083.
DOI : 10.1073/pnas.93.22.12490

C. F. Mooij, Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia?, Clin Endocrinol (Oxf), vol.73, issue.2, pp.137-183

M. S. Kim and D. P. Merke, Cardiovascular Disease Risk in Adult Women with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency, Seminars in Reproductive Medicine, vol.27, issue.04, pp.316-337, 2009.
DOI : 10.1055/s-0029-1225259

E. F. Roche, Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Clin Endocrinol J Clin Endocrinol Metab, vol.58, issue.423, pp.589-96, 2003.

A. Zimmermann, Alterations in Lipid and Carbohydrate Metabolism in Patients with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency, Hormone Research in Paediatrics, vol.74, issue.1, pp.41-50
DOI : 10.1159/000313368

N. W. Cheung and D. Helmink, Gestational diabetes, Journal of Diabetes and its Complications, vol.20, issue.1, pp.21-26, 2006.
DOI : 10.1016/j.jdiacomp.2005.05.001

J. Jaaskelainen, R. Voutilainen, and H. , Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency Fractures and bone mineral density in adult women with 21-hydroxylase deficiency, Clin Endocrinol J Clin Endocrinol Metab, vol.45, issue.612, pp.707-720, 1996.

M. Gussinye, Bone Mineral Density in Prepubertal and in Adolescent and Young Adult Patients With the Salt-wasting Form of Congenital Adrenal Hyperplasia, PEDIATRICS, vol.100, issue.4, pp.671-675, 1997.
DOI : 10.1542/peds.100.4.671

M. S. Cabrera, M. G. Vogiatzi, M. I. New, and N. , Long term outcome in adult males with classic congenital adrenal hyperplasia High prevalence of reduced fecundity in men with congenital adrenal hyperplasia Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia, J Clin Endocrinol Metab J Clin Endocrinol Metab Eur J Endocrinol, vol.86, issue.1663, pp.1665-70, 2001.

H. L. Claahsen-van-der-grinten, Testicular tumors in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency show functional features of adrenocortical tissue Normal spermatogenesis in adult males with congenital adrenal hyperplasia after discontinuation of therapy Success of glucocorticoid replacement therapy on fertility in two adult males with 21-CAH homozygote classic form, J Clin Endocrinol Metab Z.M., Illig R J Endocrinol Invest, vol.92, issue.39711, pp.20-690, 1997.

N. Radfar, Evidence for endogenous LH suppression in a man with bilateral testicular tumors and congenital adrenal hyperplasia, J Clin Endocrinol Metab, issue.6, pp.45-1194, 1977.

R. Jaaskelainen and . Voutilainen, Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life, Acta Paediatrica, vol.45, issue.2, pp.183-190, 2000.
DOI : 10.1111/j.1651-2227.2000.tb01213.x

J. Jaaskelainen, A. Tiitinen, R. Voutilainen-nordenskjold, and A. , Sexual function and fertility in adult females and males with congenital adrenal hyperplasia Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia, Horm Res J Clin Endocrinol Metab, vol.56, issue.572, pp.73-80, 2001.

R. B. Barnes, Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women, J Clin Endocrinol Metab, issue.5, pp.79-1328, 1994.

A. Casteras, Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate, Clinical Endocrinology, vol.58, issue.Suppl. 3, pp.833-840, 2009.
DOI : 10.1515/JPEM.1999.12.1.89

F. Gastaud, Impaired Sexual and Reproductive Outcomes in Women with Classical Forms of Congenital Adrenal Hyperplasia, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.4, pp.1391-1397, 2007.
DOI : 10.1210/jc.2006-1757

D. P. Merke, Approach to the Adult with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.3, pp.653-60, 2008.
DOI : 10.1210/jc.2007-2417